Alterative expression of the collagenase and adhesion molecules in the highly metastatic clones of human colonic cancer cell lines

Clinical and Experimental Metastasis

Volumn 16, Issue 5, 1998, Pages 461-469

  Nakayama, Yoshifumi ^a   Okazaki, Keisuke ^a   Shibao, Kazunori ^a   Sako, Tatsuhiko ^a   Hirata, Keiji ^a   Nagata, Naoki ^a   Kuwano, Michihiko ^b   Itoh, Hideaki ^a  

^a UNIVERSITY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH   (Japan)

^b NONE

Author keywords

Adhesion molecule; Collagenase; Colonic cancer; Metastasis

Indexed keywords

CELL ADHESION MOLECULE; COLLAGENASE; GELATINASE A; MESSENGER RNA; UVOMORULIN;

ANTIGEN EXPRESSION; ARTICLE; BLOOD GROUP LEWIS SYSTEM; CANCER CELL CULTURE; COLON CANCER; COLONY FORMATION; FLOW CYTOMETRY; HUMAN; HUMAN CELL; METASTASIS; MONOLAYER CULTURE; NORTHERN BLOTTING;

ANTIGENS, CD; ANTIGENS, CD44; ANTIGENS, NEOPLASM; BLOTTING, NORTHERN; CADHERINS; CELL ADHESION MOLECULES; CELL COMMUNICATION; CELL LINE; COLLAGENASES; COLONIC NEOPLASMS; ENDOTHELIUM, VASCULAR; FLOW CYTOMETRY; HUMANS; INTEGRIN ALPHA3; INTEGRINS; MATRIX METALLOPROTEINASE 1; NEOPLASM METASTASIS; TISSUE INHIBITOR OF METALLOPROTEINASE-2; TUMOR CELLS, CULTURED;

EID: 0032451507     PISSN: 02620898     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1006537609469     Document Type: Article

References (56)

1. Nicolson GL, 1982, Cancer metastasis: organ colonization and the cell surface properties of malignant cells. Biochem Biophys Acta, 695, 113-76.
2. Poste G and Fidler IJ, 1980, The pathogenesis of cancer metastasis. Nature, 283, 139-46.
3. Liotta LA, Rao CN and Wewer UM, 1986, Biochemical interactions of tumor cells with the basement membrane. A Rev Biochem, 55,1037-57.
4. Morikawa K, Walker SM, Jessup JM and Fidler IJ, 1988, In vivo selection of highly metastatic cells from surgical specimens of different primary human colon carcinomas implanted into nude mice. Cancer Res, 48, 1943-48.
5. Morikawa K, Walker SM, Nakajima M, Pathak S, Jessup JM and Fidler IJ, 1988, Influence of organ environment on the growth, selection, and metastasis of human colon carcinoma cells in nude mice. Cancer Res, 48, 6863-71.
6. Liotta LA and Stetler-Stevenson WG, 1991, Tumor invasion and metastasis: an imbalance of positive, negative regulation. Cancer Res, 51, 5054-59.
7. Woolley DE, 1984, Collagenolytic mechanisms in tumor cell invasion. Cancer Metastasis Rev, 3, 361-72.
8. Nakayama Y, Kohno K, Nomura Y, et al. 1993, Enhanced invasive activity and decreased expression of tissue inhibitors of metalloproteinases by hepatocyte growth factor in human renal cancer cells. The Cancer Journal, 6, 213-19.
9. Mackay AR, Corbitt RH and Thorgeirsson UP, 1990, Basement membrane type IV collagen degradation: evidence for the involvement of a proteolytic cascade independent of metalloproteinases. Cancer Res, 50, 5997-6001.
10. Hoff SD, Irimura T, Matushita Y, Ota DM, Cleary KR and Hakomori S, 1990, Metastatic potential of colon carcinoma: expression of ABO/Lewis-related antigens. Arch Surg, 125, 206-9.
11. Wiggers T, Arends JW, Schutte B, Volovics and Bosman FT, 1988, A multivariate analysis of pathologic prognosis indicators in large bowel cancer. Cancer, 61, 386-95.
12. de Vries JE, Dinjens WNM, De Bruyne GK, et al. 1995, In vivo and in vitro invasion in relation to phenotypic characteristics of human colorectal carcinoma cells. Br J Cancer, 71, 271-7.
13. Takeuchi K, Yamaguchi A, Urano T, Goi T, Nakagawara G and Shiku H, 1995, Expression of CD44 variant exon 8-10 in colorectal cancer and its relationship to metastasis. Jpn J Cancer Res, 86, 292-7.
14. Takada A, Ohmori K, Yoneda T, et al. 1993, Contribution of carbohydrate antigens Sialyl Lewis A and Sialyl Lewis X to adhesion of human cancer cells to vascular endothelium. Cancer Res, 53, 354-61.
15. Kannagi R, Fukushi Y, Tachikawa T, et al. 1986, Quantitative and qualitative characterization of cancer-associated serum glycoprotein antigens expressing fucosyl or sialyl-fucosyl type 2 chain polylactosamine. Cancer Res, 46, 2619-26.
16. Kannagi R, Kitahara A, Itai S, et al. 1988, Quantitative and qualitative characterization of cancer-associated serum glycoprotein antigens expressing epitopes consisting sialyl or sialyl-fucosyl type 1 chain. Cancer Res, 48, 3856-63.
17. a as a new prognostic factor for patients with advanced colorectal carcinoma. Cancer, 75, 2051-6.
18. Nigam AK, Savage FJ, Boulos PB, Stamp GWH, Liu D and Pignatelli M, 1993, Loss of cell-cell and cell-matrix adhesion molecules in colorectal cancer. Br J Cancer, 68, 507-14.
19. Mulder JWR, Kruyt PM, Sewnath M, et al. 1994, Colorectal cancer prognosis and expression of exon-v6-containing CD44 proteins. Lancet, 344, 1470-2.
20. Weitzman JB, Pasqualini R, Takada Y and Hemner ME, 1993, The function and distinctive regulation of the integrin VLA-3 in cell adhesion, spreading, and homotypic cell aggregation. J Biol Chem, 263, 8651-7.
21. Elices MJ, Urry LA and Hemler ME, 1991, Receptor functions for the integrin VLA-3: fibronectin, collagen, and laminin binding are differentially influenced by Arg-Gly-Asp peptide and by divalent cations. J Cell Biol, 112, 169-81.
22. Rousselle P and Aumailley M, 1994, Kalinin is more efficient than laminin in promoting adhesion of primary keratinocytes and some other epithelial cells and has a different requirement for integrin receptors. J Cell Biol, 125, 205-14.
23. Delwel GO, de Hogervorst MA, Jaspars LH, et al. 1994, Distinct and overlapping ligand specificities of the alpha 3A beta 1 and alpha 6A beta 1 integrins: recognition of laminin isoforms. Mol Biol Cell, 5, 203-15.
24. Stallmach A, v. Lampe B, Matthes H, Bornhoft G and Riecken E, 1992, Diminished expression of integrin adhesion molecules on human colonic epithelial cells during the benign to malignant tumor transformation. Gut, 33, 342-6.
25. Verde P, Stoppelli MP and Blasi F, 1984, Identification, primary sequence of an unspliced human urokinase poly(A)+ RNA. Proc Natl Acad Sci USA, 81, 4727-31.
26. Schleef RR, Bevilacqa MP and Loskutoff DJ, 1988, Cytokine activation of vascular endothelium. J Biol Chem, 263, 5797-803.
27. Goldberg GI, Marmer BL and He CS, 1989, Human 72-kilodalton type IV collagenase forms a complex with a tissue inhibitor of metalloproteinases designated TIMP-2. Proc Natl Acad Sci USA, 86, 8207-11.
28. Carmichael DF, Sommer A and Stricklin GP, 1986, Primary structure, cDNA cloning of human fibroblast collagenase inhibitor. Proc Natl Acad Sci USA, 83, 2407-11.
29. Sato H, Kida Y and Seiki M, 1992, Expression of genes encoding type IV collagen-degrading metalloproteinases, tissue inhibitors of metalloproteinases in various human tumor cells. Oncogene, 7, 77-83.
30. Bottaro DP, Rubin JS and Aaronson SA, 1991, The hepatocyte growth factor receptor is the c-met proto oncogene product. Science, 251, 802-4.
31. Nakayama Y, Naito S, Ryuto M et al. 1996, An in vitro invasion model for human renal cell carcinoma cell lines mimicking their metastatic abilities. Clin Exp Metastasis, 14, 466-74.
32. Okamura K, Morimoto A, Hamanaka R, et al. 1992, A model system for tumor angiogenesis: involvement of transforming growth factor-α in tube formation of human microvascular endothelial cells induced by esophageal cancer cells. Biochem Biophys Res Commun, 186, 1471-9.
33. Tomita Y, Saito T, Saito K, Oite T, Shimizu F and Sato S, 1995, Possible signification of VLA-4(α4β1 ) for hematogenous metastasis of renal-cell cancer. Int J Cancer, 60, 753-8.
34. Arbini A, Melchiori A, Santi L, Liotta LA, Brown PD and Stetler-Stevenson WG, 1991, Tumor cell invasion inhibited by TIMP-2. J Natl Cancer Inst, 83, 775-9.
35. Mayerhoffer A, S-Borowski K, Watkins S and Gratzl M, 1992, Cultured microvascular endothelial cells derived from the bovine corpus luteum possess NCAM-140. Exp Cell Res, 201, 545-8.
36. Basson CT, Knowles WJ, Bell L, et al. 1990, Spatiotemporal segregation of endothelial cell integrin and nonintegrin extracellular matrix-binding proteins during adhesion events. J Cell Biol, 110, 789-801.
37. Brady HR, Spertini O, Jimenez W, Brenner BM, Marsden PA and Tedder TF, 1992, Neutrophils, monocytes, and lymphocytes bind to cytokine-activated kidney glomerular endothelial cells through L-selectin (LAM-1) in vitro. J Immunol, 149, 2437-44.
38. Irimura T and Reading CL, 1987, Surface properties of metastatic tumor cells. Cancer Bull, 39, 132-41.
39. Goetz DJ, Ding H, Atkinson WJ, et al. 1996, A human colon carcinoma cell line exhibits adhesive interaction with P-selectin under fluid flow via a PSGL-1-independent mechanism. Am J Pathol, 149, 1661-73.
40. x in colorectal cancer metastasis. Dis Colon Rectum, 40, 420-31.
41. x carbohydrate antigen: liver colonization and adhesion to vascular endothelial cells. Exp Cell Res, 216, 215-21.
42. Pignatelli M, Ansari TW, Gunter P, et al. 1994, Loss of membranous E-cadherin expression in pancreatic cancer: correlation with lymph node metastasis, high grade, and advanced stage. J Pathol, 174, 243-8.
43. Bringuier PP, Umbas R, Schaafsma HE, Karthaus HFM, Debruyne FMJ and Schalken JA, 1993, Decreased E-cadherin immunoreactivity correlates with poor survival in patients with bladder tumors. Cancer Res, 53, 3241-5.
44. Oka K, Shiozaki H, Kobayashi K, et al. 1993, Expression of E-cadherin cell adhesion molecules in human breast tissues and its relationship to metastasis. Cancer Res, 53, 1696-701.
45. Oka K, Shiozaki H, Kobayashi K, et al. 1992, Immunohistochemical evaluation of E-cadherin adhesion molecule expression in human gastric cancer. Virchows Archiv A Pathol Anat, 421, 149-56.
46. van Der Wurff AAM, Arends J-W, van Der Linden EPM, Kate JT and Bosman FT, 1994, L-CAM expression in lymph node and liver metastases of colorectal carcinomas. J Pathol, 172, 177-82.
47. Schipper JH, Frixen UH, Behrens J, Unger A, Jahnke K and Birchmeier W, 1991, E-cadherin expression in squamous cell carcinomas of head and neck: inverse correlation with tumor dedifferentiation and lymph node metastasis. Cancer Res, 51, 6328-37.
48. Kitadai Y, Bucana CD, Eliis LM, Anzai H, Tahara E and Fidler IJ, 1995, In situ mRNA hybridization technique for analysis of metastasis-related gene in human colon carcinoma cells. Am J Pathol, 147, 1238-47.
49. Wielenga VJM, Heider K-H, Offerhais GJA, et al. 1993, Expression of CD44 variant proteins in human colorectal cancer is related to tumor progression. Cancer Res, 53, 4754-56.
50. Pignatelli M, Smith M and Bodmer, 1990, Low expression of collagen receptors in moderate and poorly differentiated colorectal adenocarcinomas. Br J Cancer, 61, 636-8.
51. Kuniyasu H, Yasui W, Kitadai Y, Yokozaki H, Ito H and Tahara E, 1992, Frequent amplification of the c-met gene in scirrhous type stomach cancer. Biochem Biophys Res Commun, 189, 227-32.
52. Park M, Dean M, Cooper CS, et al. 1986, Mechanism of met oncogene activation. Cell, 45, 895-904.
53. Giordano S, Ponzetto C, Di Renzo MF, Cooper CS and Comoglio PM, 1989, Tyrosine kinase receptor indistinguishable from the c-met protein. Nature, 339, 155-6.
54. Liu C, Park M and Tsao MS, 1992, Overexpression of c-met proto-oncogene but not epidermal growth factor receptor or c-erbB-2 in primary human colorectal carcinomas. Oncogene, 7, 181-5.
55. Kuniyasu H, Yasui W, Yokozaki H, Kitadai Y and Tahara E, 1993, Aberrant expression of c-met in human gastric carcinomas. Int J Cancer, 55, 72-5.
56. Faletto DL, Kaplan DR, Halveson DO, Rosen EM and Vande Woude GF, 1993, Signal transduction in c-met mediated motogenesis. In: Hepatocyte growth factor-scatter factor(HGF-SF) and c-met receptor. pp. 107-30.